Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01483690 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
A Phase 1 study, sponsored by Therapeutic Advances in Childhood Leukemia Consortium.
- Terminated
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT01483690 is a Phase 1 study that was terminated before completion, run by Therapeutic Advances in Childhood Leukemia Consortium. The registered enrollment target is 23 participants.
The verdict
NCT01483690, a Phase 1 study, was terminated before completion, sponsored by Therapeutic Advances in Childhood Leukemia Consortium.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a pilot study using decitabine and vorinostat before and during chemotherapy with vincristine, dexamethasone, mitoxantrone, and peg-asparaginase in pediatric patients with acute lymphoblastic leukemia (ALL).
Interventions
- DRUG Decitabine
- DRUG Dexamethasone
- DRUG Vincristine
- DRUG Mitoxantrone
- DRUG Vorinostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01483690
The ClinicalTrials.gov registry entry for NCT01483690 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Therapeutic Advances in Childhood Leukemia Consortium, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Decitabine is the first listed.
NCT01483690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01483690 about?
NCT01483690 is a clinical study titled "A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL". This is a pilot study using decitabine and vorinostat before and during chemotherapy with vincristine, dexamethasone, mitoxantrone, and peg-asparaginase in pediatric patients with acute lymphoblastic leukemia (ALL).
What is the current status of trial NCT01483690?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2011-12. Estimated completion is 2015-07-31.
What interventions are being tested in trial NCT01483690?
The interventions under investigation include: Decitabine (DRUG), Dexamethasone (DRUG), Vincristine (DRUG), Mitoxantrone (DRUG), Vorinostat (DRUG).
Who is sponsoring clinical trial NCT01483690?
This trial is sponsored by Therapeutic Advances in Childhood Leukemia Consortium, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.